TABLE OF CONTENTS 1 INDUSTRY OVERVIEW 1.1 PCSK9 Inhibitors Industry 1.1.1 PCSK9 Inhibitors Overview 1.1.2 Terminology Definition in the Report 1.1.2.1 Capacity 1.1.2.2 Sales Volume 1.1.2.3 Sales Revenue 1.1.2.4 Ex-factory Price & Sales Price 1.1.2.5 Cost 1.1.2.6 Gross Margin 1.2 Products & Services Overview Scope 1.3 PCSK9 Inhibitors in the Industry Chain 1.4 Industry Dynamics & Regulations 1.5 Global Market Overview 2 UPSTREAM & MANUFACTURING 2.1 Raw Materials / Components 2.2 Procurement Methods & Channels 2.3 Cost Structure & Manufacturing 2.4 Industry Capacity Overview 2.5 Production Distribution by Geography 2.5.1 Production in Major Regions / Countries 2.5.2 Trade Flow Overview 3 PRODUCT SEGMENT 3.1 Product Segmentation Market (2017 to 2021E) 3.1.1 Epatha Evolocumab Market 3.1.2 Praluent Alirocumab Market 3.1.3 Bococizumab Market 3.1.4 Others Market 3.2 Market Status 4 APPLICATION / END-USE SEGMENT 4.1 Application Segmentation Market (2016 to 2021E) 4.1.1 Clinical Application Market 4.1.2 Drug Development Market 4.1.3 Others Market 4.2 Market Status 5 NORTH AMERICA 5.1 North America Market Growth 5.2 North America Market by Countries 5.3 Major Countries Market Growth 5.3.1 United States Market Size and Growth (2016-2021E) 5.3.2 Canada Market Size and Growth (2016-2021E) 5.3.3 Mexico Market Size and Growth (2016-2021E) 6 EUROPE 6.1 Europe Market Growth 6.2 Europe Market by Countries 6.3 Major Countries Market Growth 6.3.1 Germany Market Size and Growth (2016-2021E) 6.3.2 UK Market Size and Growth (2016-2021E) 6.3.3 France Market Size and Growth (2016-2021E) 6.3.4 Russia Market Size and Growth (2016-2021E) 6.3.5 Italy Market Size and Growth (2016-2021E) 6.3.6 Rest of Europe Market Size and Growth (2016-2021E) 7 ASIA-PACIFIC 7.1 ASIA-PACIFIC Market Growth 7.2 ASIA-PACIFIC Market by Countries 7.3 Major Countries Market Growth 7.3.1 China Market Size and Growth (2016-2021E) 7.3.2 India Market Size and Growth (2016-2021E) 7.3.3 Japan Market Size and Growth (2016-2021E) 7.3.4 South Korea Market Size and Growth (2016-2021E) 7.3.5 Southeast Asia Market Size and Growth (2016-2021E) 7.3.6 Australia Market Size and Growth (2016-2021E) 7.3.7 Rest of Asia Pacific Market Size and Growth (2016-2021E) 8 SOUTH AMERICA 8.1 South America Market Growth 8.2 South America Market by Countries 8.3 Major Countries Market Growth 8.3.1 Brazil Market Size and Growth (2016-2021E) 8.3.2 Argentina Market Size and Growth (2016-2021E) 8.3.3 Rest of South America Market Size and Growth (2016-2021E) 9 MIDDLE EAST & AFRICA 9.1 Middle East and Africa Market Growth 9.2 Middle East and Africa Market by Countries 9.3 Major Countries Market Growth 9.3.1 GCC Market Size and Growth (2016-2021E) 9.3.2 North Africa Market Size and Growth (2016-2021E) 9.3.3 South Africa Market Size and Growth (2016-2021E) 9.3.4 Rest of Middle East & Africa Market Size and Growth (2016-2021E) 10 MARKET FORECAST 10.1 Global Market Forecast Overview 10.2 Global Market Forecast by Type 10.3 Global Market Forecast by Application / End-Use 10.4 Global Market Forecast by Region 11 COMPETITION OF MAJOR PLAYERS 11.1 Amgen (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.1.1 Amgen Profile 11.1.2 Amgen Products & Services Overview 11.1.3 Amgen Main Business 11.1.4 Amgen Business Operation 11.2 Eli Lilly (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.2.1 Eli Lilly Profile 11.2.2 Eli Lilly Products & Services 11.2.3 Eli Lilly Main Business 11.2.4 Eli Lilly Business Operation 11.3 Sanofi (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.3.1 Sanofi Profile 11.3.2 Sanofi Products & Services 11.3.3 Sanofi Main Business 11.3.4 Sanofi Business Operation 11.4 Pfizer (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.4.1 Pfizer Profile 11.4.2 Pfizer Products & Services 11.4.3 Pfizer Main Business 11.4.4 Pfizer Business Operation 11.5 Novartis (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.5.1 Novartis Profile 11.5.2 Novartis Products & Services 11.5.3 Novartis Main Business 11.5.4 Novartis Business Operation 11.6 Roche (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.6.1 Roche Profile 11.6.2 Roche Products & Services 11.6.3 Roche Main Business 11.6.4 Roche Business Operation 11.7 Merck (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.7.1 Merck Profile 11.7.2 Merck Products & Services 11.7.3 Merck Main Business 11.7.4 Merck Business Operation 11.8 Alnylam (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.8.1 Alnylam Profile 11.8.2 Alnylam Products & Services 11.8.3 Alnylam Main Business 11.8.4 Alnylam Business Operation 11.9 AstraZeneca (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.9.1 AstraZeneca Profile 11.9.2 AstraZeneca Products & Services 11.9.3 AstraZeneca Main Business 11.9.4 AstraZeneca Business Operation 11.10 Affiris (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.10.1 Affiris Profile 11.10.2 Affiris Products & Services 11.10.3 Affiris Main Business 11.10.4 Affiris Business Operation 11.11 BMS (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.11.1 BMS Profile 11.11.2 BMS Products & Services 11.11.3 BMS Main Business 11.11.4 BMS Business Operation 11.12 Ionis Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.12.1 Ionis Pharmaceuticals Profile 11.12.2 Ionis Pharmaceuticals Products & Services 11.12.3 Ionis Pharmaceuticals Main Business 11.12.4 Ionis Pharmaceuticals Business Operation 11.13 Cyon Therapeutics (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.13.1 Cyon Therapeutics Profile 11.13.2 Cyon Therapeutics Products & Services 11.13.3 Cyon Therapeutics Main Business 11.13.4 Cyon Therapeutics Business Operation 11.14 Daiichi Sankyo (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.14.1 Daiichi Sankyo Profile 11.14.2 Daiichi Sankyo Products & Services 11.14.3 Daiichi Sankyo Main Business 11.14.4 Daiichi Sankyo Business Operation 12 COMPANY COMPETITION 12.1 Global Sales by Company 12.1.1 Global Sales by Company 12.1.2 Global Sales Share by Company 12.2 Price & Gross Margin 12.3 Landscape of Major Companies in the Market 12.3.1 Major Companies Product Type List 12.3.1 Manufacturing Regions and Headquarters of Major Companies 12.3.1 Mergers & Acquisitions 12.4 Competitive Environment for New Entrants 12.4.1 Michael Porter's Five Forces Model 12.4.2 SWOT 13 ENVIRONMENT OVERVIEW 13.1 Impact of COVID-19 13.2 Geopolitics Overview 13.3 Economic Overview of Major Countries 14 RESEARCH CONCLUSION

LIST OF TABLE TABLE ~ PCSK9 Inhibitors Industry Dynamics & Regulations List TABLE ~ Global PCSK9 Inhibitors Sales Volume, Revenue, Price, Cost and Margin, 2016-2021E TABLE ~ Epatha Evolocumab Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Epatha Evolocumab Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Praluent Alirocumab Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Praluent Alirocumab Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Bococizumab Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Bococizumab Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global PCSK9 Inhibitors Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global PCSK9 Inhibitors Market Size by Type, 2016-2021E, in Volume TABLE ~ Clinical Application Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Clinical Application Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Drug Development Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Drug Development Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global PCSK9 Inhibitors Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global PCSK9 Inhibitors Market Size by Type, 2016-2021E, in Volume TABLE ~ North America PCSK9 Inhibitors Sales by Countries 2016-2021E, in USD Million TABLE ~ North America PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in USD Million TABLE ~ North America PCSK9 Inhibitors Sales by Countries 2016-2021E, in Volume TABLE ~ North America PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in Volume TABLE ~ United States Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Canada Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Mexico Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Europe PCSK9 Inhibitors Sales by Countries 2016-2021E, in USD Million TABLE ~ Europe PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Europe PCSK9 Inhibitors Sales by Countries 2016-2021E, in Volume TABLE ~ Europe PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in Volume TABLE ~ Germany Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ UK Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ France Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Russia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Italy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Europe Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ ASIA-PACIFIC PCSK9 Inhibitors Sales by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC PCSK9 Inhibitors Sales by Countries 2016-2021E, in Volume TABLE ~ ASIA-PACIFIC PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in Volume TABLE ~ China Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ India Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Japan Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Korea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Southeast Asia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Australia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Asia Pacific Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South America PCSK9 Inhibitors Sales by Countries 2016-2021E, in USD Million TABLE ~ South America PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in USD Million TABLE ~ South America PCSK9 Inhibitors Sales by Countries 2016-2021E, in Volume TABLE ~ South America PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in Volume TABLE ~ Brazil Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Argentina Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of South America Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Middle East and Africa PCSK9 Inhibitors Sales by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa PCSK9 Inhibitors Sales by Countries 2016-2021E, in Volume TABLE ~ Middle East and Africa PCSK9 Inhibitors Sales Share by Countries 2016-2021E, in Volume TABLE ~ GCC Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ North Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Middle East & Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Global PCSK9 Inhibitors Sales Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global PCSK9 Inhibitors Sales Share Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global PCSK9 Inhibitors Sales Forecast by Type 2022F-2026F, in Volume TABLE ~ Global PCSK9 Inhibitors Sales Share Forecast by Type 2022F-2026F, in Volume TABLE ~ Global PCSK9 Inhibitors Sales Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global PCSK9 Inhibitors Sales Share Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global PCSK9 Inhibitors Sales Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global PCSK9 Inhibitors Sales Share Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global PCSK9 Inhibitors Sales Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global PCSK9 Inhibitors Sales Share Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global PCSK9 Inhibitors Sales Forecast by Region 2022F-2026F, in Volume TABLE ~ Global PCSK9 Inhibitors Sales Share Forecast by Region 2022F-2026F, in Volume TABLE ~ Amgen Overview List TABLE ~ Products & Services List of Amgen TABLE ~ Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Eli Lilly Overview List TABLE ~ Products & Services List of Eli Lilly TABLE ~ Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Sanofi Overview List TABLE ~ Products & Services List of Sanofi TABLE ~ Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Pfizer Overview List TABLE ~ Products & Services List of Pfizer TABLE ~ Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Novartis Overview List TABLE ~ Products & Services List of Novartis TABLE ~ Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Roche Overview List TABLE ~ Products & Services List of Roche TABLE ~ Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Merck Overview List TABLE ~ Products & Services List of Merck TABLE ~ Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Alnylam Overview List TABLE ~ Products & Services List of Alnylam TABLE ~ Business Operation of Alnylam (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ AstraZeneca Overview List TABLE ~ Products & Services List of AstraZeneca TABLE ~ Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Affiris Overview List TABLE ~ Products & Services List of Affiris TABLE ~ Business Operation of Affiris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ BMS Overview List TABLE ~ Products & Services List of BMS TABLE ~ Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Ionis Pharmaceuticals Overview List TABLE ~ Products & Services List of Ionis Pharmaceuticals TABLE ~ Business Operation of Ionis Pharmaceuticals (Sales Revenue, Cost, Gross Margin) TABLE ~ Cyon Therapeutics Overview List TABLE ~ Products & Services List of Cyon Therapeutics TABLE ~ Business Operation of Cyon Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Daiichi Sankyo Overview List TABLE ~ Products & Services List of Daiichi Sankyo TABLE ~ Business Operation of Daiichi Sankyo (Sales Revenue, Cost, Gross Margin) TABLE ~ Global PCSK9 Inhibitors Sales by Company 2016-2021E, in USD Million TABLE ~ Global PCSK9 Inhibitors Sales by Company 2016-2021E, in Volume TABLE ~ Global PCSK9 Inhibitors Sales Share by Company 2016-2021E, in USD Million TABLE ~ Global PCSK9 Inhibitors Sales Share by Company 2016-2021E, in Volume TABLE ~ Global PCSK9 Inhibitors Sales Price by Company 2016-2021E, in USD/Volume TABLE ~ Global PCSK9 Inhibitors Gross Margin by Company 2016-2021E TABLE ~ Major Companies Product Type List TABLE ~ Major Companies Product Type List TABLE ~ Mergers & Acquisitions in the Market